Nazila Habibizad Net Worth & Insider Trades
Nazila Habibizad - See Remarks, Global Blood Therapeutics, Inc
What is Nazila Habibizad's Net Worth?
The current estimated net worth of Global Blood Therapeutics, Inc's See Remarks, Nazila Habibizad, is estimated to be about $1.02M . Nazila Habibizad owns about 8,918 units of Global Blood Therapeutics, Inc common stock. In the last 8 months at Global Blood Therapeutics, Inc, Nazila Habibizad has sold an estimated value of $460.52K worth.
What is Nazila Habibizad's Past Insider Trading?
Nazila Habibizad's largest sale order was 4,678 units , worth over $314.31K on August 19, 2022. In total, Nazila Habibizad has made about 8 transactions over 8 months of their time at Global Blood Therapeutics, Inc. Nazila Habibizad usually trades in September, October and August, with the busiest year in 2022.
Nazila Habibizad
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Nazila Habibizad's' Mailing Address?
- Mailing address is C/o Global Blood Therapeutics, Inc. 181 Oyster Point Blvd South San Francisco CA 94080 CA
Global Blood Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Ted Love, M.D. | 2020 | $661,250 | - | $11,778,840 | $4,693,666 | $467,000 | $5,000 | $17,605,756 |
| Ted Love, M.D. | 2019 | $596,876 | - | $4,359,600 | $4,595,717 | $540,000 | $5,000 | $10,097,193 |
| Ted Love, M.D. | 2018 | $568,750 | - | $4,648,800 | $4,623,690 | $414,000 | $5,000 | $10,260,240 |
| David Johnson | 2020 | $463,750 | - | $4,037,361 | $1,582,504 | $234,000 | $5,000 | $6,322,615 |
| David Johnson | 2019 | $453,125 | - | $1,211,000 | $1,267,784 | $250,000 | $5,000 | $3,186,909 |
| David Johnson | 2018 | $355,000 | $75,000 | $1,897,750 | $1,898,534 | $169,000 | $5,000 | $4,394,284 |
| Jeffrey Farrow | 2020 | $457,813 | - | $3,708,261 | $1,582,504 | $231,500 | $5,000 | $5,985,078 |
| Jeffrey Farrow | 2019 | $440,625 | - | $1,211,000 | $1,267,784 | $244,000 | $5,000 | $3,168,409 |
| Jeffrey Farrow | 2018 | $425,938 | - | $1,370,800 | $1,326,469 | $201,000 | $5,000 | $3,329,207 |
| Jung Choi | 2020 | $433,125 | - | $3,708,261 | $1,582,504 | $219,000 | $5,000 | $5,947,890 |
| Jung Choi | 2019 | $416,875 | - | $1,211,000 | $1,267,784 | $231,000 | $5,000 | $3,131,659 |
| Jung Choi | 2018 | $392,063 | - | $1,370,800 | $1,326,469 | $185,000 | $5,000 | $3,279,332 |
| Tricia Suvari | 2020 | $422,499 | - | $3,708,261 | $1,582,504 | $214,000 | $5,000 | $5,932,264 |
| Tricia Suvari | 2019 | $403,125 | - | $1,211,000 | $1,267,784 | $223,000 | $5,000 | $3,109,909 |
| Tricia Suvari | 2018 | $386,875 | - | $1,549,600 | $1,515,964 | $183,000 | $5,000 | $3,640,439 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1629137/000119312521136815/d97499ddef14a.htm
What are Global Blood Therapeutics, Inc's Past Insider Trades?
Global Blood Therapeutics, Inc's most recent insider trade came on September 6, 2022 by Jeffrey Farrow who sold 33,326 units worth $2.27M . In the last 7 years, insiders at Global Blood Therapeutics, Inc have sold an estimated value of $167.81M and bought an estimated value of $17.45M worth of shares. Insider trading is most common in June, with the busiest year in 2022. The most active traders at the company are Jung Choi, See Remarks, Ted Love, President and CEO, and Borga Tricia Suvari, Chief Legal Officer .
Global Blood Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||